Cardiology News and Research

Latest Cardiology News and Research

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

$SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction$

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure patients with mildly reduced and preserved ejection fraction.

28 Aug 2022

Trial shows superiority of AI in assessing cardiac function to sonographer assessment

In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by artificial intelligence (AI) is superior to initial sonographer assessment, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Target blood pressure of 77 mmHg provides no benefit for comatose cardiac arrest survivors

A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in comatose cardiac arrest survivors compared with a 63 mmHg target, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.

28 Aug 2022

Restrictive oxygenation target in comatose, post cardiac arrest patients does not cause harm

A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac arrest does not worsen survival or neurological outcome compared with a liberal target, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

A randomized trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower the risk of death, heart attack and stroke in 65 to 69 year-olds.

28 Aug 2022

Adding acetazolamide to intravenous loop diuretics decreases congestion in patients with acute decompensated heart failure

Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

New advice aims to reduce the cardiac side effects of cancer treatment

The first European Society of Cardiology Guideline on cardio-oncology is published online today in European Heart Journal.

26 Aug 2022

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

26 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

First patient version of the ESC Guidelines on cardiovascular disease prevention unveiled today

The first patient version of the European Society of Cardiology Guidelines on cardiovascular disease prevention are unveiled today at ESC Congress 2022.

26 Aug 2022

Basic life support training essential for all people to improve survival from cardiac arrest

Basic life support training in schools and communities is essential to improve survival from cardiac arrest, according to European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal.

26 Aug 2022

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the European Society of Cardiology (ESC) and European Respiratory Society (ERS) Guidelines for the diagnosis and treatment of pulmonary hypertension, published online today in European Heart Journal and the European Respiratory Journal.

26 Aug 2022

Suboptimal sleep linked with higher risk of heart disease and stroke

Nine in ten people do not get a good night's sleep, according to research presented at ESC Congress 2022.

26 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Previous
1
...
58
59
60
61
62
63
64
...
2495
Next

Cardiology News and Research

Latest Cardiology News and Research

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

Trial shows superiority of AI in assessing cardiac function to sonographer assessment

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

Target blood pressure of 77 mmHg provides no benefit for comatose cardiac arrest survivors

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

Restrictive oxygenation target in comatose, post cardiac arrest patients does not cause harm

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

Adding acetazolamide to intravenous loop diuretics decreases congestion in patients with acute decompensated heart failure

New advice aims to reduce the cardiac side effects of cancer treatment

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Study compares the benefits of taking antihypertensive medication in the morning or evening

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

First patient version of the ESC Guidelines on cardiovascular disease prevention unveiled today

Basic life support training essential for all people to improve survival from cardiac arrest

New guidelines recommend earlier detection and treatment of pulmonary hypertension

Suboptimal sleep linked with higher risk of heart disease and stroke

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Industry Focus: Cell & Gene Therapy eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Cardiology News and Research

Latest Cardiology News and Research

Industry Focus: Cell & Gene Therapy eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in